A PhD neuroscientist trained in behavioral neuroscience, addiction and pain processing, and neurodegenerative diseases including Parkinson's disease, Huntington's disease, ALS and Alzheimer's disease. Twenty years' industry experience including animal models, in vitro and ex vivo functional molecular pharmacology, toxicology and clinical trial planning. I have led an Alzheimer's disease therapeutic candidate from target discovery, med chem, lead optimization, IND-enabling toxicology to Phase 2…